nicotinamide mononucleotide has been researched along with Insulin Resistance in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 7 (87.50) | 2.80 |
| Authors | Studies |
|---|---|
| Aflatounian, A; Bertoldo, MJ; Cochran, BJ; Edwards, MC; Gilchrist, RB; Ledger, WL; Paris, VR; Richani, D; Walters, KA; Wu, LE | 1 |
| Apte, RS; Bhargava, A; Bhasin, S; Cheng, M; Ghattas-Puylara, C; Latham, N; Lavu, S; Lawney, B; Lin, AP; Livingston, D; Memish-Beleva, Y; Merugumala, S; Orkaby, AR; Ozimek, NE; Pencina, KM; Reid, KF; Sinclair, DA; Storer, T; Swain, PM; Valderrabano, R; Wilson, L; Wipper, B | 1 |
| Franczyk, MP; Imai, SI; Kayser, BD; Klein, S; Mills, KF; Patterson, BW; Patti, GJ; Pietka, T; Sindelar, M; Yoshino, J; Yoshino, M | 1 |
| Bass, J; Hepler, C | 1 |
| Brenner, C | 1 |
| Klein, S; Yoshino, M | 1 |
| Fischer-Posovszky, P; Roos, J; Zinngrebe, J | 1 |
| Franczyk, MP; Imai, S; Kelly, SC; Moseley, AC; Qi, N; Stromsdorfer, KL; Yamaguchi, S; Yoon, MJ; Yoshino, J | 1 |
2 trial(s) available for nicotinamide mononucleotide and Insulin Resistance
| Article | Year |
|---|---|
Nicotinamide Adenine Dinucleotide Augmentation in Overweight or Obese Middle-Aged and Older Adults: A Physiologic Study.
Topics: Aged; Body Weight; Cholesterol; Humans; Insulin Resistance; Middle Aged; NAD; Nicotinamide Mononucleotide; Obesity; Overweight | 2023 |
Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women.
Topics: Aged; Body Composition; Dietary Supplements; Double-Blind Method; Female; Humans; Insulin; Insulin Resistance; Middle Aged; Mitochondria, Muscle; Muscle, Skeletal; NAD; Nicotinamide Mononucleotide; Obesity; Overweight; Postmenopause; Prediabetic State; RNA-Seq; Signal Transduction | 2021 |
6 other study(ies) available for nicotinamide mononucleotide and Insulin Resistance
| Article | Year |
|---|---|
Declining muscle NAD
Topics: Animals; Dihydrotestosterone; Female; Humans; Hyperandrogenism; Insulin Resistance; Lipids; Metabolic Syndrome; Mice; Muscle, Skeletal; NAD; Nicotinamide Mononucleotide; Obesity; Polycystic Ovary Syndrome | 2022 |
Supplements to treat prediabetes.
Topics: Dietary Supplements; Female; Humans; Insulin Resistance; Muscles; Nicotinamide Mononucleotide; Prediabetic State | 2021 |
Comment on "Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women".
Topics: Female; Humans; Insulin Resistance; Liver; Muscles; Nicotinamide Mononucleotide; Prediabetic State | 2021 |
Response to Comment on "Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women".
Topics: Female; Humans; Insulin Resistance; Muscles; Nicotinamide Mononucleotide; Prediabetic State; Triglycerides | 2021 |
Nicotinamide mononucleotide: a potential effective natural compound against insulin resistance.
Topics: Biological Products; Female; Humans; Insulin; Insulin Resistance; NAD; Nicotinamide Mononucleotide; Overweight; Randomized Controlled Trials as Topic | 2021 |
NAMPT-Mediated NAD(+) Biosynthesis in Adipocytes Regulates Adipose Tissue Function and Multi-organ Insulin Sensitivity in Mice.
Topics: Adipocytes; Adiponectin; Adipose Tissue; Animals; Cyclin-Dependent Kinase 5; Cytokines; Fatty Acids, Nonesterified; Female; Gene Expression Regulation; Hypoglycemic Agents; Insulin Resistance; Liver; Male; Mice; Mice, Knockout; Muscle, Skeletal; Nicotinamide Mononucleotide; Nicotinamide Phosphoribosyltransferase; Obesity; Phosphorylation; PPAR gamma; Rosiglitazone; Signal Transduction; Thiazolidinediones | 2016 |